OHE was awarded a UK Department of Health grant to further develop three aspects of health status indexes. Results of the second of these, advances in Time Trade Off methodology, are reported in this post.

This publication expands on the series of posts published earlier on this blog.   It reports on a seminar intended to encourage further thought about the distinguishing characteristics of the market for biosimilars and...

OHE collaborated with the Centre for Health Economics of the University of York in hosting workshop for policy makers and their advisers on NHS reforms. Discussion centred on economic evidence needed to drive the reforms and the gaps that now exist. The post reports key concerns and observations.

Value-based pricing for new medicines, proposed as part of UK health care reform, would create a QALY-plus approach for drugs approved starting 1 January 2014. For new drugs, this would replace the current PPRS system. The implications for pricing and reimbursement, and innovation, are outlined by Prof Towse in this blog post.

Members of the OHE team participated in a number of sessions at ISPOR’s 13th Annual European Congress in November. This post summarizes the contributions of Prof Nancy Devlin, OHE’s Director of Research.